Sara Belli

1.8k total citations
22 papers, 444 citations indexed

About

Sara Belli is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sara Belli has authored 22 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sara Belli's work include Drug Transport and Resistance Mechanisms (8 papers), Lipid Membrane Structure and Behavior (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Sara Belli is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Lipid Membrane Structure and Behavior (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Sara Belli collaborates with scholars based in Switzerland, United States and Germany. Sara Belli's co-authors include Stefanie D. Krämer, Heidi Wunderli‐Allenspach, Rubén Alvarez‐Sánchez, Claudia S. Neuhaus, Hélène E. Aschmann, Katja Heinig, Antonello Caruso, Cyrill Brunner, Franz Schuler and Christoph Funk and has published in prestigious journals such as NeuroImage, Cancer Research and Advanced Drug Delivery Reviews.

In The Last Decade

Sara Belli

21 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Belli Switzerland 14 257 125 56 46 38 22 444
Cathie Xiang United States 13 184 0.7× 118 0.9× 68 1.2× 19 0.4× 120 3.2× 17 572
Sylvain Broussy France 16 424 1.6× 75 0.6× 29 0.5× 26 0.6× 7 0.2× 37 724
Erik L. Meredith United States 15 375 1.5× 68 0.5× 33 0.6× 29 0.6× 74 1.9× 22 760
Silvia Pace Italy 15 250 1.0× 143 1.1× 32 0.6× 23 0.5× 6 0.2× 33 506
Narayanan Surendran United States 12 146 0.6× 107 0.9× 9 0.2× 53 1.2× 18 0.5× 22 462
Fabienne Z. Gaugaz Sweden 7 212 0.8× 157 1.3× 19 0.3× 74 1.6× 4 0.1× 13 471
Suresh P. Sulochana India 13 170 0.7× 103 0.8× 21 0.4× 65 1.4× 11 0.3× 60 472
Patricia Zane United States 11 104 0.4× 39 0.3× 22 0.4× 48 1.0× 9 0.2× 15 474
Marina Tintelnot‐Blomley Switzerland 17 463 1.8× 71 0.6× 24 0.4× 15 0.3× 12 0.3× 29 879

Countries citing papers authored by Sara Belli

Since Specialization
Citations

This map shows the geographic impact of Sara Belli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Belli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Belli more than expected).

Fields of papers citing papers by Sara Belli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Belli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Belli. The network helps show where Sara Belli may publish in the future.

Co-authorship network of co-authors of Sara Belli

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Belli. A scholar is included among the top collaborators of Sara Belli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Belli. Sara Belli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Janz, Philipp, Frédéric Knoflach, Konrad Bleicher, et al.. (2023). Selective oxytocin receptor activation prevents prefrontal circuit dysfunction and social behavioral alterations in response to chronic prefrontal cortex activation in male rats. Frontiers in Cellular Neuroscience. 17. 1 indexed citations
3.
Bredack, Christoph, Sara Belli, Peter J. Mohr, et al.. (2023). Evaluation of Tetrazine Tracers for Pretargeted Imaging within the Central Nervous System. Bioconjugate Chemistry. 34(10). 1882–1893. 3 indexed citations
4.
5.
Hauri, Simon, et al.. (2020). Understanding the Half-Life Extension of Intravitreally Administered Antibodies Binding to Ocular Albumin. Pharmaceutics. 12(9). 810–810. 6 indexed citations
6.
Jacobsen, Björn, et al.. (2019). A minimally-invasive serial cerebrospinal fluid sampling model in conscious Göttingen minipigs. Journal of Biological Methods. 6(1). 1–1. 6 indexed citations
7.
Neuhaus, Claudia S., Björn Wagner, Hélène E. Aschmann, et al.. (2017). Kinetics of lipid bilayer permeation of a series of ionisable drugs and their correlation with human transporter-independent intestinal permeability. European Journal of Pharmaceutical Sciences. 104. 150–161. 20 indexed citations
8.
9.
Krämer, Stefanie D., et al.. (2016). When barriers ignore the “rule-of-five”. Advanced Drug Delivery Reviews. 101. 62–74. 56 indexed citations
10.
Wang, Ying, Aleksey Lomakin, Sonoko Kanai, et al.. (2016). The molecular basis for the prolonged blood circulation of lipidated incretin peptides: Peptide oligomerization or binding to serum albumin?. Journal of Controlled Release. 241. 25–33. 33 indexed citations
11.
Belli, Sara, Bjoern Wagner, Michael Honer, et al.. (2015). Estimation of Drug Binding to Brain Tissue: Methodology and in Vivo Application of a Distribution Assay in Brain Polar Lipids. Molecular Pharmaceutics. 12(12). 4529–4541. 11 indexed citations
12.
Eyer, Klaus, Friedrich Schuler, Phillip Kuhn, et al.. (2013). A liposomal fluorescence assay to study permeation kinetics of drug-like weak bases across the lipid bilayer. Journal of Controlled Release. 173. 102–109. 50 indexed citations
13.
Caruso, Antonello, Rubén Alvarez‐Sánchez, Alexander Hillebrecht, et al.. (2013). PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimation. Biochemical Pharmacology. 85(11). 1684–1699. 24 indexed citations
14.
Poirier, Agnès, Sara Belli, Christoph Funk, et al.. (2012). Role of the Intestinal Peptide Transporter PEPT1 in Oseltamivir Absorption: In Vitro and In Vivo Studies. Drug Metabolism and Disposition. 40(8). 1556–1565. 14 indexed citations
15.
Haller, Stephanie, Franz Schuler, Stanley E. Lazic, et al.. (2012). Expression Profiles of Metabolic Enzymes and Drug Transporters in the Liver and along the Intestine of Beagle Dogs. Drug Metabolism and Disposition. 40(8). 1603–1610. 27 indexed citations
16.
Heinig, Katja, et al.. (2011). Determination of Ganciclovir and its prodrug Valganciclovir by hydrophilic interaction liquid chromatography–tandem mass spectrometry. Journal of Chromatography B. 879(5-6). 436–442. 31 indexed citations
17.
Mu, Linjing, Michael Honer, Sara Belli, et al.. (2011). In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5). NeuroImage. 56(3). 984–991. 14 indexed citations
18.
Maira, Giovanni Di, et al.. (2008). Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis. Molecular and Cellular Biochemistry. 316(1-2). 155–161. 26 indexed citations
19.
Belli, Sara, et al.. (2008). Cholesterol-Mediated Activation of P-Glycoprotein: Distinct Effects on Basal and Drug-Induced ATPase Activities. Journal of Pharmaceutical Sciences. 98(5). 1905–1918. 34 indexed citations
20.
Belli, Sara, et al.. (2007). P-Glycoprotein in Proteoliposomes with Low Residual Detergent: The Effects of Cholesterol. Pharmaceutical Research. 24(11). 1993–2004. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cathie Xiang Breakdown of academic impact, for papers by Sylvain Broussy Breakdown of academic impact, for papers by Erik L. Meredith Breakdown of academic impact, for papers by Silvia Pace Breakdown of academic impact, for papers by Narayanan Surendran Breakdown of academic impact, for papers by Fabienne Z. Gaugaz Breakdown of academic impact, for papers by Suresh P. Sulochana Breakdown of academic impact, for papers by Patricia Zane Breakdown of academic impact, for papers by Marina Tintelnot‐Blomley
Rankless by CCL
2026